Literature DB >> 7556315

Intractable diarrhoea in infancy in the 1990s: a survey in Italy.

A Ventura1, D Dragovich.   

Abstract

UNLABELLED: A "quick" prevalence study of intractable diarrhoea (defined as diarrhoea lasting more than 3 weeks and dependent on parenteral nutrition [PN] for more than 50% of daily caloric intake) was conducted by FAX. All 35 paediatric gastroenterology services which had been contacted answered questionnaire sent by FAX. 20 cases of intractable diarrhoea were identified in 9 centres. In 12 cases PN was administered at home, the other 8 cases being treated as inpatients for an average duration of 9.5 months. A diagnosis had been established in 11 out of 20 cases. Auto-immune enteropathy was the most frequent diagnosis (5 cases); congenital microvillous atrophy (3 cases); chronic pseudo-obstruction (2 cases) and multiple food intolerance (1 case). Undefined 9/20 cases presented atrophy of intestinal mucosa. The age of the beginning of diarrhoea varied from 2 days to 12 years, but was more than 16 months only in some cases with auto-immune enteropathy.
CONCLUSION: Intractable diarrhoea has a low prevalence in Italy and remains a rare but very intricating problem. Long-term PN is recommended in most cases: autoimmune enteropathy is the most frequent cause but in about half of the cases the aetiopathogenetic diagnosis is still not defined.

Entities:  

Mesh:

Year:  1995        PMID: 7556315     DOI: 10.1007/bf02074826

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Protracted diarrhoea of infancy: evidence in support of an autoimmune variant.

Authors:  R Mirakian; A Richardson; P J Milla; J A Walker-Smith; J Unsworth; M O Savage; G F Bottazzo
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

Review 2.  DNA probes for diagnosis of intestinal infection.

Authors:  S Char; M J Farthing
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

3.  Antibiotics and cholestyramine in the treatment of persistent diarrhea in infants.

Authors:  M D Bowie
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-05       Impact factor: 2.839

4.  Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea.

Authors:  A Cravioto; A Tello; A Navarro; J Ruiz; H Villafán; F Uribe; C Eslava
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

5.  Classification of intractable diarrhea in infancy using clinical and immunohistological criteria.

Authors:  B Cuenod; N Brousse; O Goulet; S De Potter; J F Mougenot; C Ricour; D Guy-Grand; N Cerf-Bensussan
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

6.  Protracted diarrhoea in infancy. Analysis of 82 cases with particular reference to diagnosis and management.

Authors:  V F Larcher; R Shepherd; D E Francis; J T Harries
Journal:  Arch Dis Child       Date:  1977-08       Impact factor: 3.791

7.  Familial microvillous atrophy: a clinicopathological survey of 23 cases.

Authors:  A D Phillips; J Schmitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1992-05       Impact factor: 2.839

Review 8.  Nutritional management of acute diarrhea: an appraisal of the alternatives.

Authors:  K H Brown; W C MacLean
Journal:  Pediatrics       Date:  1984-02       Impact factor: 7.124

9.  Cryptosporidium, chronic diarrhoea and the proximal small intestinal mucosa.

Authors:  A D Phillips; A G Thomas; J A Walker-Smith
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 10.  Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition.

Authors:  J H Vargas; P Sachs; M E Ament
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 May-Jun       Impact factor: 2.839

View more
  1 in total

1.  A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy.

Authors:  I Kobayashi; K Imamura; M Yamada; M Okano; A Yara; S Ikema; N Ishikawa
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.